-3:14966

Seyma Büyücek1, Nina Schraps2, Anne Menz1

  • 1Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany.

Biomarker research
|December 10, 2024
PubMed
概括

克劳丁-3 (CLDN3) 在许多癌症中高度表达,使其成为潜在的药物标. 减少CLDN3表达与细胞癌 (RCC) 的较差结果有关,这表明其预后价值.